Naloxone Hydrochloride Spray
Product Images NDC 68001-645

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 68001-645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Naloxone 4mg Carton 01-2025 (Naloxone 4mg Carton 01 2025)

Naloxone 4mg Carton 01-2025 (Naloxone 4mg Carton 01 2025)
This is a drug information sheet for Naloxone HCI Nasal Spray 4 mg. The document provides detailed instructions on how to administer the medication in case of an opioid overdose. It includes steps such as checking for an overdose, administering the first dose in the nose, calling 911, observing the person's response, and staying until the ambulance arrives. The text also mentions warnings, storage information, inactive ingredients, and contact details for questions. The nasal spray is designed for emergency treatment of opioid overdose and is safe to use even if opioids are not present. The product is manufactured by Padagis in Israel and distributed by BluePoint Laboratories.*
FDA Label Image

Holding Nasal Spray Device (Device)

Holding Nasal Spray Device (Device)
FDA Label Image

Step 1 (Step1)

Step 1 (Step1)
FDA Label Image

Step 2 (Step2)

Step 2 (Step2)
FDA Label Image

Step 3 (Step3)

Step 3 (Step3)
FDA Label Image

Step 4 (Step4)

Step 4 (Step4)
FDA Label Image

Step 5 (Step5)

Step 5 (Step5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.